DrugBank -- a comprehensive resource for in silico drug discovery and exploration
What you can do:
Combines detailed drug data with comprehensive drug target and drug action information.
Highlights:
- Since its first release in 2006, DrugBank has been widely used to facilitate in silico drug target discovery, drug design, drug docking or screening, drug metabolism prediction, drug interaction prediction and general pharmaceutical education.
- The latest version of DrugBank (release 2.0) has been expanded significantly over the previous release. With approximately 4900 drug entries, it now contains 60% more FDA-approved small molecule and biotech drugs including 10% more 'experimental' drugs. Significantly, more protein target data has also been added to the database, with the latest version of DrugBank containing three times as many non-redundant protein or drug target sequences as before (1565 versus 524).
- Each DrugCard entry now contains more than 100 data fields with half of the information being devoted to drug/chemical data and the other half devoted to pharmacological, pharmacogenomic and molecular biological data.
- A number of new data fields, including food-drug interactions, drug-drug interactions and experimental ADME data have been added in response to numerous user requests.
- DrugBank has also significantly improved the power and simplicity of its structure query and text query searches.
Keywords:
- drug information
- drug target information
- in silico drug target discovery
- drug design
- drug docking
- drug screening
- drug metabolism
- drug metabolic pathways
- drug interaction prediction
- pharmacology
- pharmaceuticals
Literature & Tutorials:
This record last updated: 04-04-2008